0000899243-23-016904.txt : 20230705 0000899243-23-016904.hdr.sgml : 20230705 20230705164653 ACCESSION NUMBER: 0000899243-23-016904 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230620 FILED AS OF DATE: 20230705 DATE AS OF CHANGE: 20230705 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Reilly Thomas Charles CENTRAL INDEX KEY: 0001827590 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21392 FILM NUMBER: 231069977 MAIL ADDRESS: STREET 1: C/O CARA THERAPEUTICS, INC. STREET 2: 4 STAMFORD PLAZA, 107 ELM STREET CITY: STAMFORD STATE: CT ZIP: 06902 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMARIN CORP PLC\UK CENTRAL INDEX KEY: 0000897448 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: SPACES SOUTH DOCKLANDS, BLOCK C STREET 2: 77 SIR JOHN ROGERSON'S QUAY CITY: DUBLIN 2 STATE: L2 ZIP: D02 VK60 BUSINESS PHONE: 353 1 6699 020 MAIL ADDRESS: STREET 1: SPACES SOUTH DOCKLANDS, BLOCK C STREET 2: 77 SIR JOHN ROGERSON'S QUAY CITY: DUBLIN 2 STATE: L2 ZIP: D02 VK60 FORMER COMPANY: FORMER CONFORMED NAME: AMARIN PHARMACEUTICALS PLC DATE OF NAME CHANGE: 20000201 FORMER COMPANY: FORMER CONFORMED NAME: ETHICAL HOLDINGS PLC DATE OF NAME CHANGE: 19930322 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-20 0 0000897448 AMARIN CORP PLC\UK AMRN 0001827590 Reilly Thomas Charles C/O AMARIN PHARMA, INC. 440 US HIGHWAY 22 BRIDGEWATER NJ 08807 0 1 0 0 SVP and CFO 0 Ordinary Shares 2023-07-01 4 M 0 16667 A 33584 D Ordinary Shares 2023-07-01 4 F 0 8209 1.19 D 25375 D Restricted Stock Units 0.00 2023-07-01 4 M 0 16667 0.00 D Ordinary Shares 16667 33333 D The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share. On February 21, 2023, the Issuer's Remuneration Committee of its Board of Directors certified the achievement of certain performance metrics for this Restricted Stock Unit ("RSU") award, resulting in the grant of 50,000 RSUs scheduled to vest in three equal installments on each of the first, second and third anniversary of the grant date of July 1, 2022, subject to the Reporting Person's continued service to the Issuer. Not applicable. Represents withholding by the Issuer of shares in respect of tax liability incident to the vesting of a security issued in accordance with Rule 16b-3, and not a market sale of securities. Each RSU represents a contingent right to receive one Ordinary Share or cash in lieu thereof at the Issuer's discretion. By: /s/ Thomas Charles Reilly 2023-07-05